Understanding the logistics for the distribution of heme in cells AE Gallio, SSP Fung, A Cammack-Najera, AJ Hudson, EL Raven JACS Au 1 (10), 1541-1555, 2021 | 46 | 2021 |
Unravelling the mechanisms controlling heme supply and demand GCH Leung, SSP Fung, AE Gallio, R Blore, D Alibhai, EL Raven, ... Proceedings of the National Academy of Sciences 118 (22), e2104008118, 2021 | 27 | 2021 |
Suprachoroidal space triamcinolone acetonide: a review in uveitic macular edema S Fung, YY Syed Drugs 82 (13), 1403-1410, 2022 | 22 | 2022 |
Durvalumab: a review in advanced biliary tract cancer S Fung, YY Syed Targeted Oncology 18 (6), 965-972, 2023 | 10 | 2023 |
Precise determination of heme binding affinity in proteins GCH Leung, SSP Fung, NRB Dovey, EL Raven, AJ Hudson Analytical biochemistry 572, 45-51, 2019 | 10 | 2019 |
Satralizumab: A review in neuromyelitis optica spectrum disorder S Fung, M Shirley CNS drugs 37 (4), 363-370, 2023 | 9 | 2023 |
Baricitinib: a review in severe alopecia areata S Fung, M Shirley American Journal of Clinical Dermatology 24 (4), 661-668, 2023 | 6 | 2023 |
Ripretinib: a review in gastrointestinal stromal tumours as fourth-or later-line of therapy S Fung, M Shirley Drugs 82 (15), 1541-1548, 2022 | 6 | 2022 |
Abemaciclib: A review in early breast cancer with a high risk of recurrence S Fung, HA Blair Targeted Oncology 18 (2), 287-294, 2023 | 2 | 2023 |
Sovateltide in cerebral ischaemic stroke: a profile of its use S Fung, YY Syed Drugs & Therapy Perspectives 40 (7), 250-255, 2024 | 1 | 2024 |
Oteseconazole in recurrent vulvovaginal candidiasis: a profile of its use S Fung, M Shirley Drugs & Therapy Perspectives 39 (8), 263-269, 2023 | 1 | 2023 |
Management of central neuropathic pain involves many drugs but few have proven efficacy S Fung, C Kang Drugs & Therapy Perspectives 39 (1), 1-7, 2023 | 1 | 2023 |
Correction to: Suprachoroidal Space Triamcinolone Acetonide: A Review in Uveitic Macular Edema S Fung, YY Syed Drugs 82 (13), 1411-1411, 2022 | 1 | 2022 |
A molecular docking strategy for identifying fragment inhibitors of indoleamine 2, 3-dioxygenase 1 (IDO1) S Fung, JU Flanagan, CJ Squire, BD Palmer, LM Ching Cancer Research 74 (19_Supplement), 5372-5372, 2014 | 1 | 2014 |
Initiate treatment with inflammatory modulators early in adult-onset Still’s disease C Fenton, S Fung Drugs & Therapy Perspectives, 1-4, 2025 | | 2025 |
Recommend existing COVID-19 vaccines to reduce serious illness but new vaccines are needed to prevent transmission S Fung Drugs & Therapy Perspectives, 1-6, 2024 | | 2024 |
Eradicate Helicobacter pylori in older patients with quad or triple therapy C Fenton, S Fung Drugs & Therapy Perspectives 40 (11), 450-454, 2024 | | 2024 |
Relieve the intense itch of chronic prurigo with old and new therapies C Fenton, S Fung Drugs & Therapy Perspectives, 1-4, 2024 | | 2024 |
Mirikizumab in moderately to severely active ulcerative colitis: a profile of its use S Fung, HA Blair Drugs & Therapy Perspectives, 1-11, 2024 | | 2024 |
Screen high-risk paediatric patients for non-infectious uveitis and consider its treatment options S Fung Drugs & Therapy Perspectives 40 (8), 304-309, 2024 | | 2024 |